This post-pandemic review evaluates the bidirectional relationship between SARS-CoV-2 infection and diabetes, covering pathophysiological mechanisms (pancreatic effects, insulin resistance), meta-analyses on incident type 1 and type 2 diabetes post-COVID-19, long COVID–diabetes links, and the impact of vaccination on diabetes risk.
Diabetes was one of the strongest early predictors of severe COVID-19 outcomes and mortality; the review synthesizes evidence that SARS-CoV-2 infection may also trigger new-onset diabetes, though the strength and causality of this association vary by study quality, with prospective cohorts and registry studies providing the highest-quality data.
- Underlying epidemiologic studies often relied on preliminary or conflicting evidence from early pandemic conditions. - Causality between SARS-CoV-2 infection and incident diabetes remains unresolved due to heterogeneity in study designs. - Critical knowledge gaps persist, particularly around long COVID and diabetes and the durability of vaccination's protective effect.
Clinicians should monitor patients with a history of COVID-19 for new-onset diabetes, especially those with risk factors, and consider vaccination as a potential modifier of post-infection diabetes risk. Recognize that early pandemic data on COVID-19 severity in diabetes patients shaped care frameworks that may need reappraisal as higher-quality evidence matures.
Explore related topics
